scispace - formally typeset
R

Richard De Boer

Researcher at Peter MacCallum Cancer Centre

Publications -  69
Citations -  4110

Richard De Boer is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Breast cancer & Metastatic breast cancer. The author has an hindex of 22, co-authored 69 publications receiving 3596 citations. Previous affiliations of Richard De Boer include Marche Polytechnic University & Royal Melbourne Hospital.

Papers
More filters
Journal ArticleDOI

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martin, +622 more
- 01 Dec 2017 - 
TL;DR: 1 year of extended adjuvant therapy with neratinib, administered after chemotherapy and trastuzumab, significantly reduced the proportion of clinically relevant breast cancer relapses-ie, those that might lead to death, such as distant and locoregional relapses outside the preserved breast-without increasing the risk of long-term toxicity.
Journal ArticleDOI

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

TL;DR: The vandetanib combination showed a significantly higher objective response rate and a significant delay in the time to worsening of lung cancer symptoms versus the placebo arm as well as an acceptable safety profile in this patient population.